Phase II Clinical Trial of Sipatrigine (619C89) by Continuous Infusion in Acute Stroke.

Completed

Phase 2 Results

Summary of Purpose

To study the safety and efficacy of sipatrigine in acute stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 February 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, placebo-controlled study of 27 patients.

Contacts

Not available